{
  "type": "hyp",
  "text": "Tat an early regulatory protein that is critical for viral gene expression and replication transactivates the HIV-1 long terminal repeat (LTR) via its binding to the transactivation response element (TAR) and along with other cellular factors increases viral transcription initiation and elongation. NF-kappaB suppression by Tat occurred at the transcriptional level was mediated by the CD40-responsive element in the IL-1 beta promoter and was exclusively dependent on the 29 amino acids encoded by the second exon NF-kappaB element.\n",
  "self": {
    "NER": {
      "answers": [
        "HIV-1",
        "TAR",
        "Tat",
        "IL-1",
        "29",
        "second"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "Tat transactivates the long terminal repeat of what virus?",
          "What does Tat bind to?",
          "What protein suppresses NF-kappaB?",
          "What is the TAR of the TAR?",
          "How many amino acids are encoded by the second exon NF-kappaB",
          "What exon of the NF-kappaB is required for suppression?"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "an early regulatory protein",
        "viral gene expression",
        "replication",
        "the HIV-1 long terminal repeat",
        "LTR",
        "its binding",
        "the transactivation response element",
        "TAR",
        "other cellular factors",
        "viral transcription initiation",
        "elongation",
        "NF-kappaB suppression",
        "Tat",
        "the transcriptional level",
        "the CD40-responsive element",
        "the IL-1 beta promoter",
        "the 29 amino acids",
        "the second exon NF-kappaB element"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What is Tat?",
          "Tat is critical for what?",
          "Tat is critical for viral gene expression and what else?",
          "Tat transactivates what?",
          "What does Tat transactivate?",
          "What is the mechanism by which Tat transactivates the HIV-1 long terminal repeat?",
          "What does Tat bind to?",
          "What does Tat bind to?",
          "Tat increases viral transcription initiation and elongation along with what?",
          "Tat increases what?",
          "Tat increases viral transcription initiation and what?",
          "What is Tat dependent on?",
          "What protein suppresses NF-kappaB?",
          "Where does NF-kappaB suppression occur?",
          "What mediated NF-kappaB suppression?",
          "What is the CD40-responsive element in?",
          "What is Tat dependent on?",
          "What amino acid encodes Tat?"
        ]
      }
    }
  },
  "asked": {
    "What patient had a NF-kappaB suppression?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.07341927289962769,
        "ground_truth": {
          "RCC": {
            "bertscore": 0.6816696524620056,
            "f1": 0
          }
        }
      }
    },
    "What was the purpose of the study?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0007644891738891602,
        "ground_truth": {
          "We": {
            "bertscore": 0.6054112315177917,
            "f1": 0
          }
        }
      }
    },
    "What did we determine about NF-kappaB suppression in RCC patients?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.010172367095947266,
        "ground_truth": {
          "the mechanism": {
            "bertscore": 0.7001519203186035,
            "f1": 0
          }
        }
      }
    },
    "What did we determine in T cells of RCC patients?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.000525057315826416,
        "ground_truth": {
          "NF-kappaB suppression": {
            "bertscore": 0.6412151455879211,
            "f1": 0
          }
        }
      }
    },
    "What type of cells were tested in a RCC patient?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 4.9948692321777344e-05,
        "ground_truth": {
          "T cells": {
            "bertscore": 0.6607831716537476,
            "f1": 0
          }
        }
      }
    },
    "What type of patient had NF-kappaB suppression?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.001981019973754883,
        "ground_truth": {
          "RCC patient": {
            "bertscore": 0.659152626991272,
            "f1": 0
          }
        }
      }
    },
    "What did we determine about the T cells of RCC patients?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.00021308660507202148,
        "ground_truth": {
          "whether supernatant fluid": {
            "bertscore": 0.6705071926116943,
            "f1": 0
          }
        }
      }
    },
    "What type of cells were used to determine the suppression of NF-kappaB?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.029440701007843018,
        "ground_truth": {
          "RCC explants": {
            "bertscore": 0.6627346873283386,
            "f1": 0
          }
        }
      }
    }
  }
}